Gross Profit - Imexpharm Corp (VN:IMP) - Alpha Spread
I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 48 650 VND -0.71%
Market Cap: 3.7T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Gross Profit Peer Comparison

Comparables:
H
DHT
C
DCL
D
DMC
D
DHG
T
TRA

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Gross Profit
â‚«767.6B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
8%
H
HaTay Pharmaceutical JSC
VN:DHT
Gross Profit
â‚«195.6B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
4%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Gross Profit
â‚«209.9B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Gross Profit
â‚«404.2B
CAGR 3-Years
1%
CAGR 5-Years
-15%
CAGR 10-Years
-1%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Gross Profit
â‚«2.2T
CAGR 3-Years
5%
CAGR 5-Years
-5%
CAGR 10-Years
2%
T
Traphaco JSC
VN:TRA
Gross Profit
â‚«1.2T
CAGR 3-Years
-17%
CAGR 5-Years
-5%
CAGR 10-Years
6%

See Also

What is Imexpharm Corp's Gross Profit?
Gross Profit
767.6B VND

Based on the financial report for Jun 30, 2024, Imexpharm Corp's Gross Profit amounts to 767.6B VND.

What is Imexpharm Corp's Gross Profit growth rate?
Gross Profit CAGR 10Y
8%

Over the last year, the Gross Profit growth was -8%. The average annual Gross Profit growth rates for Imexpharm Corp have been 10% over the past three years , 10% over the past five years , and 8% over the past ten years .

Back to Top